Steven L Bernstein1, Yan Guo. 1. Departments of Ophthalmology, University of Maryland at Baltimore, School of Medicine, Baltimore, Maryland 21201, USA. slbernst@umaryland.edu
Abstract
PURPOSE: Displaced cholinergic amacrine cell neurons comprise a significant fraction of the retinal ganglion cell (RGC) layer. Rodent anterior ischemic optic neuropathy (rAION) is an optic nerve infarct, which results in RGC loss in mice. The goal was to determine whether rAION produces changes in amacrine cell neurons. METHODS: rAION was generated in transgenic mice carrying a cyan fluorescent reporter protein (CFP) gene linked to the Thy-1 promoter, which expresses CFP in RGCs. rAION was induced with standard parameters. Retinas were examined pre-and post-induction by retinal fundus microscopy. rAION induction severity was scored by changes in retinal transparency and RGC loss. Cholinergic amacrine cells were identified via choline acetyltransferase (ChAT) immunohistochemistry. ChAT and CFP expression was evaluated in flat-mounted retinas examined by confocal microscopy and western analysis. RESULTS: Moderate rAION induction levels (defined as early retention of retinal transparency and <70% RGC loss) did not alter amacrine cell numbers in the RGC layer, but changed the relative levels of ChAT expression by immunohistochemistry. No changes in total ChAT protein were seen. Severe rAION induction (defined as loss of retinal transparency and >70% RGC loss) resulted in a trend toward amacrine cell loss and decreased ChAT protein levels. CONCLUSIONS: There is wide disparity in mouse rAION induction levels using standardized parameters. Moderate rAION induction levels without direct retinal compromise produces isolated RGC loss, with displaced amacrine cell changes likely due to changes in RGC-amacrine communication. Severe rAION induction results in both RGC and amacrine cell loss, possibly due to intra-retinal ischemic changes.
PURPOSE: Displaced cholinergic amacrine cell neurons comprise a significant fraction of the retinal ganglion cell (RGC) layer. Rodent anterior ischemic optic neuropathy (rAION) is an optic nerve infarct, which results in RGC loss in mice. The goal was to determine whether rAION produces changes in amacrine cell neurons. METHODS: rAION was generated in transgenic mice carrying a cyan fluorescent reporter protein (CFP) gene linked to the Thy-1 promoter, which expresses CFP in RGCs. rAION was induced with standard parameters. Retinas were examined pre-and post-induction by retinal fundus microscopy. rAION induction severity was scored by changes in retinal transparency and RGC loss. Cholinergic amacrine cells were identified via choline acetyltransferase (ChAT) immunohistochemistry. ChAT and CFP expression was evaluated in flat-mounted retinas examined by confocal microscopy and western analysis. RESULTS: Moderate rAION induction levels (defined as early retention of retinal transparency and <70% RGC loss) did not alter amacrine cell numbers in the RGC layer, but changed the relative levels of ChAT expression by immunohistochemistry. No changes in total ChAT protein were seen. Severe rAION induction (defined as loss of retinal transparency and >70% RGC loss) resulted in a trend toward amacrine cell loss and decreased ChAT protein levels. CONCLUSIONS: There is wide disparity in mouse rAION induction levels using standardized parameters. Moderate rAION induction levels without direct retinal compromise produces isolated RGC loss, with displaced amacrine cell changes likely due to changes in RGC-amacrine communication. Severe rAION induction results in both RGC and amacrine cell loss, possibly due to intra-retinal ischemic changes.
Authors: G Feng; R H Mellor; M Bernstein; C Keller-Peck; Q T Nguyen; M Wallace; J M Nerbonne; J W Lichtman; J R Sanes Journal: Neuron Date: 2000-10 Impact factor: 17.173
Authors: R J Smeyne; M Vendrell; M Hayward; S J Baker; G G Miao; K Schilling; L M Robertson; T Curran; J I Morgan Journal: Nature Date: 1993-05-13 Impact factor: 49.962
Authors: Steven L Bernstein; Yan Guo; Shalom E Kelman; Robert W Flower; Mary A Johnson Journal: Invest Ophthalmol Vis Sci Date: 2003-10 Impact factor: 4.799
Authors: Francisco M Nadal-Nicolás; Manuel Jiménez-López; Paloma Sobrado-Calvo; Leticia Nieto-López; Isabel Cánovas-Martínez; Manuel Salinas-Navarro; Manuel Vidal-Sanz; Marta Agudo Journal: Invest Ophthalmol Vis Sci Date: 2009-03-05 Impact factor: 4.799
Authors: Abram Akopian; Tamas Atlasz; Feng Pan; Sze Wong; Yi Zhang; Béla Völgyi; David L Paul; Stewart A Bloomfield Journal: J Neurosci Date: 2014-08-06 Impact factor: 6.167
Authors: Jacob G Light; James W Fransen; Adewumi N Adekunle; Alice Adkins; Gobinda Pangeni; James Loudin; Keith Mathieson; Daniel V Palanker; Maureen A McCall; Machelle T Pardue Journal: Exp Eye Res Date: 2014-09-16 Impact factor: 3.467
Authors: Panida Chindasub; James D Lindsey; Karen Duong-Polk; Christopher K Leung; Robert N Weinreb Journal: Invest Ophthalmol Vis Sci Date: 2013-01-07 Impact factor: 4.799
Authors: Yan Guo; Zara Mehrabian; Mary A Johnson; Neil R Miller; Amanda D Henderson; John Hamlyn; Steven L Bernstein Journal: PLoS One Date: 2021-03-25 Impact factor: 3.240